EHAB
$13.62
Enhabit, Inc.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Enhabit, Inc. provides home health and hospice services in the United States. The company's home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical adm...
Recent News
Enhabit (EHAB) Q3 2025 Earnings Call Transcript
With me on the call this morning is Barb Jacobsmeyer, President and Chief Executive Officer; and Ryan Solomon, Chief Financial Officer. Before we begin, I want to let you know that our third quarter earnings release and supplemental information are available on our website at investors.ehab.com. On Page 2 of the supplemental information, you will find the safe harbor statements, which are also set forth in the last page of our earnings release.
Enhabit (EHAB) Q1 2025 Earnings Call Transcript
Before we begin, if you do not already have a copy, the first quarter earnings release, supplemental information and related Form 8-K filed with the SEC are available on our website at investors.ehab.com. On Page 2 of the supplemental information, you will find the Safe Harbor statements, which are also set forth on the last page of the earnings release.
Enhabit (EHAB) Q3 2024 Earnings Call Transcript
Before we begin, if you do not already have a copy, the third quarter earnings release, supplemental information, and related Form 8-K filed with the SEC are available on our website at investors.ehab.com. On Page 2 of the supplemental information, you will find the Safe Harbor Statements, which are also set forth on the last page of the earnings release. During the call, we will make forward-looking statements, which are subject to risk and uncertainties many of which are beyond our control.
A Hedge Fund Just Trimmed $2.7 Million of NCR Voyix. Should You Care?
NCR Voyix delivers technology and managed services across retail, hospitality, and financial services for enterprise clients worldwide.
How The Enhabit (EHAB) Story Is Shifting Around The US$13.80 Kinderhook Deal Price
Enhabit’s analyst fair value anchor has been reset to US$13.80 from US$13.08, aligning the reference price target with the agreed all cash acquisition level. That shift tracks closely with recent analyst commentary, where many have framed US$13.80 per share as the central benchmark for both ratings and valuation work. As you read on, you will see how this new reference point is shaping the evolving analyst narrative and what it could mean for how you think about Enhabit. Stay updated as the...